Item no. |
PD1-H52H6-20ug |
Manufacturer |
ACROBiosystems
|
Amount |
20 ug |
Quantity options |
100 ug
20 ug
100 ug x 5
|
Category |
|
Type |
Proteins Recombinant |
Format |
Powder |
Specific against |
Human (Homo sapiens) |
Host |
HEK293 |
Conjugate/Tag |
Unconjugated |
Purity |
80% |
Citations |
(1) Ishida Y., et al., 1992, EMBO J. 11 (11): 3887-95. (2) Blank C., et al., 2007, Cancer Immunol. Immunother. 56 (5): 739-45. (3) Agata Y., et al., 1996, Int. Immunol. 8 (5): 765-72. (4) Freeman GJ., et al., 2000, J. Exp. Med. 192 (7): 1027-34. (5) Latchman Y., et al., 2001, Nat. Immunol. 2 (3): 261-8. (6) Yamazaki T., et al., 2002, J. Immunol. 169 (10): 5538-45. |
NCBI |
NP_005009.2 |
ECLASS 10.1 |
32160409 |
ECLASS 11.0 |
32160409 |
UNSPSC |
12352202 |
Shipping condition |
Room temperature |
Available |
|
Manufacturer - Category |
Protein / Immune Checkpoint Proteins |
Manufacturer - Conjugate / Tag |
Unconjugated, C-10xHis |
Shipping Temperature |
RT |
Storage Conditions |
-20°C |
Molecular Weight |
30.7 kDa |
Description |
Human PD-1 Full Length, His Tag (PD1-H52H6) is expressed from human 293 cells (HEK293). It contains AA Leu 25 - Leu 288 (Accession # Q15116-1). |
Background |
Programmed cell death protein 1 (PD-1) is also known as CD279 and PDCD1, is a type I membrane protein and is a member of the extended CD28/CTLA-4 family of T cell regulators. PDCD1 is expressed on the surface of activated T cells, B cells, macrophages, myeloid cells and a subset of thymocytes. PD-1 has two ligands, PD-L1 and PD-L2, which are members of the B7 family. PD-L1 is expressed on almost all murine tumor cell lines, including PA1 myeloma, P815 mastocytoma, and B16 melanoma upon treatment with IFN-γ. PD-L2 expression is more restricted and is expressed mainly by DCs and a few tumor lines. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, coligation of PD1 inhibits BCR-mediating signal by dephosphorylating key signal transducer. In vitro, treatment of anti-CD3 stimulated T cells with PD-L1-Ig results in reduced T cell proliferation and IFN-γ secretion. Monoclonal antibodies targeting PD-1 that boost the immune system are being developed for the treatment of cancer. |
Molecule |
PD-1 |
Exp Region |
Leu 25 - Leu 288 |
Characteristics |
This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 30.7 kDa. The protein migrates as 40-120 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation. |
Endotoxin |
1.0 EU per μg |
Buffer |
50 mM Tris, 100 mM NaCl, pH 8.0 with detergent |
Stability |
● -20°C to -70°C for 12 months in lyophilized state; ● -70°C for 3 months under sterile conditions after reconstitution.For long term storage, the product should be stored at lyophilized state at -20°C or lower. |
Protectant |
trehalose |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.